Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd

Item

http://www.wikidata.org/entity/Q37878769

Q37878769

about

Antibiotics for secondary prevention of coronary heart disease Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial Macrolide antibiotics and the risk of cardiac arrhythmias Vascular smooth muscle cell apoptosis in atherosclerosis.Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus: chronic infections and coronary heart disease.Atherosclerosis, inflammation, and infection.Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease?Chlamydia pneumoniae in atherosclerosis.Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.Antibiotics in the prevention and treatment of coronary heart disease.Inflammation, infection, or both in atherosclerosis: the ROXIS trial in perspective.Collaborative multidisciplinary workshop report: clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease.Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia.Inclusion fluorescent-antibody test as a screening assay for detection of antibodies to Chlamydia pneumoniae.Atherosclerosis: an infectious disease?Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice Cell wall-deficient bacteria as a cause of infections: a review of the clinical significance.Emerging relations between infectious diseases and coronary artery disease and atherosclerosis.Weighing the evidence for infection as a risk factor for coronary heart disease.Microorganisms in the aetiology of atherosclerosis.Novel risk factors for stroke: homocysteine, inflammation, and infection.Should antibiotics now be part of routine treatment of coronary heart disease?Assessment of subclinical atherosclerosis and cardiovascular risk.Potential infectious etiologies of atherosclerosis: a multifactorial perspective Chronic infections and atherosclerosis/thrombosis.Role of antibiotics for the prevention of cardiovascular disease.Effect of clarithromycin on inflammatory markers in patients with atherosclerosis.Inflammatory and thrombotic mechanisms in coronary atherosclerosis Cardiac risks associated with antibiotics: azithromycin and levofloxacin Acute coronary syndrome and chronic infection in the Cork coronary care case-control study.Inflammation and atherosclerosis.Antibiotic trials for coronary heart disease.Absence of Bacteria on Coronary Angioplasty Balloons from Unselected Patients: Results with Use of a High Sensitivity Polymerase Chain Reaction Assay.Sophisticated tests for susceptibility to atherosclerosis: an added value for heart hospitals.Infectious agents are not necessary for murine atherogenesis.in silico analyses of metabolic pathway and protein interaction network for identification of next gen therapeutic targets in Chlamydophila pneumoniae Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical options Chlamydia pneumoniae is not detectable in subretinal neovascular membranes in the exudative stage of age-related macular degeneration.

P2860

Q24201388-7603EDFB-B885-49D0-B151-825F08A08ED5 Q33752851-D5B68096-AE3C-4991-A5B8-71BFE6CAF103 Q33772270-B20ED072-FC0A-4697-BCC4-8150AB854D0A Q33785809-7BD1F930-65E6-47F8-BF07-63BD68730080 Q33821315-DEE16490-CCE4-49DF-8AC0-8F9F8090BBF9 Q33843534-0ABD7D90-E4A9-4FB6-A9CD-C8BAE8A017E5 Q33871329-E0EDAB93-25BA-4B15-8834-8AB314344D45 Q33890410-CDD6249E-6F9B-4E51-9E00-56856D8C697F Q33935003-1A7A3AD9-0BBF-497C-BB5C-3D23FDA1F495 Q33935098-F07A7187-42E3-497D-9D8A-9794B632C5CE Q33935103-556F5954-BEC4-40BE-BB7A-6D25B998925A Q33935109-CDDCC625-B21C-4FE8-818B-6DC812B91678 Q33943151-27EE735B-2E1C-4F4F-B737-F3C38CABADB9 Q33943276-87865A7C-AA44-4C1F-ACF9-B918FA2E1825 Q33972834-204DC5A1-9268-4DB7-964F-DDCA8EF4B95C Q33979917-9493803A-A4AA-45F8-9251-5664E7F370C0 Q33984369-F47D3B73-D0A8-4B34-BD3D-ADBE2BF46028 Q33987842-BB584B65-13B4-48C8-B792-417197A9172A Q34011168-D6BEB42E-3A39-423E-8A9A-0B1D8AD6BB30 Q34065709-6EF7AA65-8F00-4665-B66B-22F02695E44A Q34107356-1FA84686-7B89-491B-9465-691EF06DE670 Q34160606-3219F0B0-A818-419B-BF48-75652693630E Q34397021-970DF137-482E-47E0-B5C9-601E9E2C6B0B Q34465370-D1144BB6-E1A2-4747-B2CB-12A64CB3FE62 Q34514051-2B0B6DF3-6D80-4475-95DA-9605C023BE7E Q34874476-6C6320C7-84FD-402E-A3B2-8F78243E1968 Q35140098-5C08103C-0B90-45E1-B44B-C98843A1ED66 Q35201247-828CB087-0ADA-45E9-90BE-E80C031114AC Q35502601-55268D75-DD99-4E67-B938-677091F85229 Q35583359-977CB816-CAE9-4E0F-907A-E7314FCA4EA9 Q35692019-6CCB68ED-A1E0-40FF-9A72-C3610DC47683 Q35733945-1BE8D4DB-D307-4B53-B085-5473AB985715 Q35875899-C135C205-51CB-4DE8-8A99-7D273E5EBC59 Q36091141-CC106B24-E30E-47CE-94D8-04DBD8F5E7A0 Q36368432-42CDAFBE-FFB4-4CD8-A520-9B9C86594057 Q37049216-A511F49B-D78B-4F7D-9408-2E62AF1F9DBE Q37346172-3766D5B4-2EF8-47A3-AB8F-CA9DC57B05B9 Q37568474-2C04D9B9-7593-4D74-884A-47118EC56330 Q37856198-DAA299BC-28E0-46B9-94CC-58ED67190BF7 Q37862257-BAC6A54E-C0A3-41E8-8DA4-F4C2761C2997

P2860

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd

Item

http://www.wikidata.org/entity/Q37878769

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 1999

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs